These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 15175)

  • 1. Effects of LSD and 2-bromo LSD on striatal DOPAC levels.
    Persson SA
    Life Sci; 1977 Apr; 20(7):1199-205. PubMed ID: 15175
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of long-term administration of 1,2,3,4-tetrahydroisoquinoline (TIQ) on striatal dopamine and 3,4-dihydroxyphenylacetic acid (DOPAC) content in mice.
    Saitoh T; Mizuno Y; Nagatsu T; Yoshida M
    Neurosci Lett; 1988 Oct; 92(3):321-4. PubMed ID: 3200488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid post mortem changes in 3,4-dihydroxyphenylacetic acid (DOPAC), a dopamine metabolite, in rat striatum.
    Moleman P; Bruinvels J; Westerink BH
    J Neurochem; 1977 Jul; 29(1):175-7. PubMed ID: 886321
    [No Abstract]   [Full Text] [Related]  

  • 4. Differential effects of acute and chronic haloperidol treatment on striatal and nigral 3,4-dihydroxyphenylacetic acid (DOPAC) levels.
    Meller E; Friedhoff AJ; Friedman E
    Life Sci; 1980 Feb; 26(7):541-7. PubMed ID: 7366335
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of LSD and 2-bromo LSD on the striatal DOPA accumulation after decarboxylase inhibition in rats.
    Persson SA
    Eur J Pharmacol; 1977 May; 43(1):73-83. PubMed ID: 16756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of morphine to increase striatal 3,4-dihydroxyphenylacetic acid in fasted rats.
    De Montis GM; Olianas MC; Di Lorenzo C; Tagliamonte A
    Eur J Pharmacol; 1978 Jan; 47(1):121-3. PubMed ID: 618726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of dopaminergic antagonists on striatal DOPAC concentrations and alpha-methyl-p-tyrosine-induced decline of dopamine following intrastriatal injections of kainic acid.
    Wuerthele SM; Moore KE
    J Pharm Pharmacol; 1979 Mar; 31(3):180-2. PubMed ID: 34696
    [No Abstract]   [Full Text] [Related]  

  • 8. In vivo voltammetric determination of the kinetics of dopamine metabolism in the rat.
    Michael AC; Justice JB; Neill DB
    Neurosci Lett; 1985 May; 56(3):365-9. PubMed ID: 4022449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Striatal DOPAC elevation predicts antipsychotic efficacy of metoclopramide.
    Stanley M; Wilk S
    Life Sci; 1979 May; 24(20):1907-12. PubMed ID: 459691
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term decreases in striatal dopamine, 3,4-dihydroxyphenylacetic acid, and homovanillic acid after a single injection of amphetamine in iprindole-treated rats: time course and time-dependent interactions with amfonelic acid.
    Steranka LR
    Brain Res; 1982 Feb; 234(1):123-36. PubMed ID: 7059818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent on-line analysis of striatal ascorbate, dopamine and dihydroxyphenylacetic acid concentrations by in vivo voltammetry.
    Gonzalez-Mora JL; Sanchez-Bruno JA; Mas M
    Neurosci Lett; 1988 Mar; 86(1):61-6. PubMed ID: 3362430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developmental change in striatal concentration of homovanillic acid and 3,4-dihydroxyphenylacetic acid in response to apomorphine and haloperidol treatment.
    Nomura Y; Komori T; Okuda S; Segawa T
    Arch Int Pharmacodyn Ther; 1979 Jan; 237(1):25-30. PubMed ID: 485682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The differential effects of morphine, oxotremorine and antipsychotic drugs on DOPAC concentrations in rat brain.
    Stanley M; Wilk S
    J Pharm Pharmacol; 1980 Aug; 32(8):567-70. PubMed ID: 6106695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-serotonergic [3H]ketanserin binding sites in striatal membranes are associated with a dopac release system on dopaminergic nerve endings.
    Leysen JE; Eens A; Gommeren W; Van Gompel P; Wynants J; Janssen PA
    Eur J Pharmacol; 1987 Feb; 134(3):373-5. PubMed ID: 3569421
    [No Abstract]   [Full Text] [Related]  

  • 15. Probenecid increases dopamine metabolite 3,4-dihydroxyphenylacetic acid (DOPAC) in rat adrenal gland.
    Kawaguchi A; Niwa M; Ozaki M
    Jpn J Pharmacol; 1983 Jun; 33(3):611-7. PubMed ID: 6620731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LSD as an agonist of dopamine receptors in the striatum.
    Pieri L; Pieri M; Haefely W
    Nature; 1974 Dec; 252(5484):586-8. PubMed ID: 4431521
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative effects of penfluridol on circling behavior and striatal DOPAC and serum prolactin concentrations in the rat.
    Annunziato LA; Wuerthele SM; Moore KE
    Eur J Pharmacol; 1978 Aug; 50(3):187-92. PubMed ID: 567584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of 3,4-dihydroxyphenylacetic acid and 3-methoxytyramine specific activity rat striatum.
    Di Giulio AM; Groppetti A; Algeri S; Ponzio F; Cattabeni F; Galli CL
    Anal Biochem; 1979 Jan; 92(1):82-90. PubMed ID: 426290
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of L-dopa and L-tyrosine on release of free and conjugated dopamine, homovanillic acid and dihydroxyphenylacetic acid from slices of rat striatum.
    Tyce GM; Rorie DK
    Life Sci; 1985 Dec; 37(25):2439-48. PubMed ID: 4079658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions between lysergic acid diethylamide and dopamine-sensitive adenylate cyclase systems in rat brain.
    Hungen KV; Roberts S; Hill DF
    Brain Res; 1975 Aug; 94(1):57-66. PubMed ID: 238721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.